Gilead Sciences Newsroom

Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $95

Futu NewsOct 8 20:32

Gilead Sciences Analyst Ratings

BenzingaOct 8 04:23

Gilead Sciences Is Maintained at Equal-Weight by Barclays

Dow JonesOct 8 02:49

Gilead Upgraded to Overweight by Wells Fargo, PrEP Launch Cited

Seeking AlphaOct 7 22:27

Wells Fargo Upgrades Gilead Sciences(GILD.US) to Buy Rating, Raises Target Price to $100

Futu NewsOct 7 18:34

Gilead Sciences (GILD) Was Upgraded to a Buy Rating at Wells Fargo

TipRanksOct 7 18:29

Barclays Sticks to Their Hold Rating for Gilead Sciences (GILD)

TipRanksOct 7 10:20

Gilead Sciences Analyst Ratings

BenzingaOct 4 22:54

RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $75

BenzingaOct 4 22:54

Redburn Atlantic Adjusts Price Target on Gilead Sciences to $123 From $119, Maintains Buy Rating

MT NewswiresOct 3 18:52

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)

TipRanksSep 24 17:12

Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $95

Futu NewsSep 24 04:32

Cantor Fitzgerald Reiterates Neutral on Gilead Sciences, Maintains $70 Price Target

BenzingaSep 16 23:47

Gilead Sciences Analyst Ratings

BenzingaSep 16 23:47

Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $95

Futu NewsSep 16 20:31

Jefferies Remains a Buy on Gilead Sciences (GILD)

TipRanksSep 16 20:21

J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating

Futu NewsSep 16 18:31

Buy Rating on Gilead Sciences: Underestimated Market Potential of Lenacapavir in HIV Treatment and Prevention

TipRanksSep 16 18:04

Hold Rating on Gilead Sciences Amid Lenacapavir's Promise and Market Uncertainties

TipRanksSep 16 14:19

Mizuho Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $90

Futu NewsSep 14 02:31